Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Innovative Industrial Properties

Jazz Pharmaceuticals

With the federal government taking steps to reschedule cannabis to Schedule III, effectively creating a form of medical cannabis legalization, the future of  cannabis stocks is under intense scrutiny. While cannabis stocks initially surged on the news, they quickly settled back to their previous levels.

3 Cannabis Stocks That Could Make Your Grandchildren Rich

The fourth edition of Breckenridge Distillery's Collectors Art Series combines the art of blending color and blending whiskey, featuring artist Abby Wren.

Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren

Aurora Cannabis

Canopy Growth

Two very powerful members of the U.S. Senate — Senate Majority Leader Chuck Schumer and Senate Finance Chairman Ron Wyden — last month reintroduced legislation that would take cannabis off the list of federal controlled substances. In my view, the legislation would therefore legalize the use of cannabis at the federal level, even though it appears that the senators are avoiding that term.

3 Cannabis Stocks to Buy on the Dip: June 2024

Marijuana hasn't been kind to investors. However, the space is starting to regain its footing due to several positive developments.

Better Growth Stock: Aurora Cannabis or Tilray Brands?

Ambev

Anheuser-Busch InBev

Cronos Group

Diageo

Green Thumb Industries Inc.

Boston Beer Company

Constellation Brands

Molson Coors Brewing

Consumer surveys in Canada and the U.S. show that alcohol consumption is down in areas where adults have the option to consume legal cannabis, Bernstein analyst Nadine Sarwat said in a research note on Friday.

Legal cannabis sales eat into beer revenue, survey data shows

Acuity Brands

Buzzfeed

Rumble Inc

Stem, Inc

Tesla

Upwork Inc

Investors can overlook underestimated stocks to buy for various reasons. In many cases, some inherent flaw or fundamental issue makes their underestimated status apparent.

7 Underestimated Stocks Poised for an Underdog Uprising

NEW YORK and SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, thereby transforming healthcare, today announced the launch of Broken Coast EU-GMP certified medical cannabis products in Australia. Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “Our highly scalable global footprint, which enables us to deliver medical cannabis globally from our facilities in Canada as well as our facilities in Europe, combined with our diverse portfolio of cannabis brands and products have been instrumental in leading the evolution of the global medical cannabis industry.

Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia

Apple Hospitality REIT

AST SpaceMobile

Great Lakes Dredge & Dock

SharkNinja Inc

You aren't alone if you're nervous about where markets are going. Though economic and stock news alike points toward renewed national financial and monetary strength, on-the-ground vibes seem to negate the apparent facts.

7 Stocks to Buy Now: June 2024

The global cannabis industry and top marijuana stocks are experiencing significant growth, making it an attractive sector for investors. Currently valued at over $20 billion, the industry is projected to reach $90 billion by 2026. The increasing legalization and acceptance of cannabis products fuel this rapid expansion. Recent headlines highlight the ongoing debate over federal legalization in the United States. These discussions could open up new markets and opportunities. As investors seek to capitalize on this growth, it's crucial to identify top-performing stocks. This week, Canadian cannabis companies are particularly noteworthy. They have strong market positions and are poised for further expansion.

June 2024: Canadian Cannabis Stocks with High Potential

Cannabis stocks might seem an easy place to park your money for intense rewards. After all, President Joe Biden – who previously played coy with the idea of legalization – announced a move to reclassify marijuana to a lesser enforcement category.

3 Smoking Hot Cannabis Stocks as Legalization Gains Momentum

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.69, moving -0.59% from the previous trading session.

Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts

Eledon Pharmaceuticals

Rigel Pharmaceuticals

Penny stocks sometimes get a bad rep due to their inherent risk. They are cheap but are considered highly volatile and have a low chance of providing substantial profit.

Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF CNBS, is renowned for recognizing the potential of the cannabis sector early on. In an exclusive interview with Benzinga Cannabis, he discussed the critical role of strategic partnerships in expanding market reach, the importance of operational efficiencies in improving gross margins and the potential of the U.S. hemp cannabinoid market as a burgeoning and legally complex segment poised for substantial growth.

Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'

SNDL Inc.

Village Farms International

Most marijuana stock investors are keeping focused on the future of the sector. Also, some have adapted to the volatile trading and consistent variables that impact trading. So for instance when a company reports bad news it lets people know there could be a possible decline in trading. But when news is reported in a positive light depending on how important it can have adverse effects on most marijuana stocks. That is why many have had to learn how to find ways to invest in a volatile sector.

The Best Marijuana Stocks To Watch Now 2024

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or “Tilray”) (Nasdaq | TSX: TLRY), a leading global lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced today a men's health initiative launching on Father's Day, June 16, 2024, with Montauk Brewing and Blue Point Brewery brands. In a world where conversations often revolve around work, sports and current events, men's health remains a largely unspoken topic.

Tilray Beverages Announces Campaign to Raise Awareness for Men's Health

Grab Holdings Ltd

IAMGOLD

Stocks with share prices under $5 are typically too risky to buy. Considering penny stocks by the Securities & Exchange Commission (SEC), such low-cost stocks trade at these depressed prices for a reason.

3 Stocks Under $5 You Should Buy Now: June 2024

Solid Power

Yatra Online

Even with a small allocation, penny stocks can be game-changers for the portfolio. If the business grows and the markets like the overall narrative, 20x or 30x returns from penny stock ideas are not a big mountain to climb.

Penny Stock Perfection: 3 Low-Priced Picks With Sky-High Potential

This summer, Good Supply cannabis spotlights their most shareable and convenient formats, with exciting flavours that are perfect for the season ahead.

Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis

Curaleaf Holdings, Inc.

Meme stocks have been rallying and it's still not too late to join the party. Attractive stocks from several sectors are yet to participate in the meme frenzy.

3 Cannabis Stocks to Buy for 200% Returns Before Year-End

Tilray Brands (TLRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -8.29% in 4 Weeks, Here's Why Tilray Brands (TLRY) Looks Ripe for a Turnaround

Cannabis and related products seller Tilray Brands (NASDAQ: TLRY ) is headquartered in Canada. However, the company seeks to expand its presence in the U.S. if/when cannabis is legally rescheduled there.

Is Tilray Stock Your Ticket to the Coming U.S. Cannabis Gold Rush?

Canopy Growth has been bullish on marijuana legalization for years, and it recently got the OK to move ahead with Canopy USA. Tilray Brands has been expanding into the U.S. via alcohol brands and businesses.

Canopy Growth vs. SNDL vs. Tilray Brands: What's the Best Pot Stock to Buy If You're Bullish on Legalization?

Tilray's Canadian cannabis brand Redecan launches 'Purple Churro' – a sensational new flower offering making its debut in time for National Churro Day.

Redecan Cannabis Introduces New Top Shelf Flower 'Purple Churro'

As the cannabis industry continues to grow, investors are closely watching top Canadian marijuana stocks this week. The global cannabis market is projected to reach $73.6 billion by 2027, with the U.S. market accounting for a significant portion. Recent news about potential federal legalization in the U.S. has fueled optimism. This could open up new opportunities for Canadian cannabis companies. With increasing demand for both medical and recreational cannabis, these companies are strategically positioned for growth. Investors should pay attention to market trends and developments. Using technical analysis can help identify buying opportunities and trends. Additionally, proper risk management is crucial to navigating this volatile market.

June 2024 Watchlist: Top Canadian Cannabis Stocks to Watch

Tickets Available Now and Through June 10th LITTLETON, Colo., June 04, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brew”), a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and 97.3 KBCO (iHeartMedia-Denver) are proud to announce the next On Tap with KBCO featuring live music at the Breckenridge Brewery in Littleton on August 10, 2024.

Breckenridge Brewery Announces 'On Tap with KBCO' Concert Series Featuring Gary Clark Jr.

News for Tilray Brands Stock (TLRY)